Hitesh Pandya, MD, MBA

Global Clinical Head, Respiratory & Inflammation
BioPharmaceuticals Research and Development, AstraZeneca, Cambridge, United Kingdom, United Kingdom

Poster(s):

• (404) Efficacy of as-needed albuterol–budesonide versus albuterol on systemic corticosteroid exposure in participants with mild asthma: BATURA prespecified analysis
  Wednesday, October 29, 2025